deltatrials
Completed NA INTERVENTIONAL NCT00001623

Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia

HLA-Matched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Updated 24 times since 2017 Last updated: Dec 11, 2019 Started: Mar 27, 1997 Primary completion: Jan 31, 2008 Completion: Aug 3, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Graft vs Host Disease and Hematologic Neoplasm and is currently completed. National Heart, Lung, and Blood Institute (NHLBI) leads this study, which shows 24 recorded versions since 1997 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Sep 2018 · 31 days · monthly snapshot~Sep 2018 – ~Oct 2018 · 30 days · monthly snapshot~Oct 2018 – ~Nov 2018 · 31 days · monthly snapshot~Nov 2018 – ~Dec 2018 · 30 days · monthly snapshot~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshot~Jan 2019 – ~Feb 2019 · 31 days · monthly snapshot~Feb 2019 – ~Mar 2019 · 28 days · monthly snapshot~Mar 2019 – ~Apr 2019 · 31 days · monthly snapshot~Apr 2019 – ~May 2019 · 30 days · monthly snapshot~May 2019 – ~Jun 2019 · 31 days · monthly snapshot~Jun 2019 – ~Jul 2019 · 30 days · monthly snapshot~Jul 2019 – ~Aug 2019 · 31 days · monthly snapshot~Aug 2019 – ~Sep 2019 · 31 days · monthly snapshot~Sep 2019 – ~Oct 2019 · 30 days · monthly snapshot~Oct 2019 – ~Nov 2019 · 31 days · monthly snapshot~Nov 2019 – ~Dec 2019 · 30 days · monthly snapshot~Dec 2019 – ~Jan 2020 · 31 days · monthly snapshot~Jan 2020 – ~Jan 2021 · 12 months · monthly snapshot~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

24 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Jan 2020 — Jan 2021 [monthly]

    Completed NA

  5. Dec 2019 — Jan 2020 [monthly]

    Completed NA

Show 19 earlier versions
  1. Nov 2019 — Dec 2019 [monthly]

    Completed NA

  2. Oct 2019 — Nov 2019 [monthly]

    Completed NA

  3. Sep 2019 — Oct 2019 [monthly]

    Completed NA

  4. Aug 2019 — Sep 2019 [monthly]

    Completed NA

  5. Jul 2019 — Aug 2019 [monthly]

    Completed NA

  6. Jun 2019 — Jul 2019 [monthly]

    Completed NA

  7. May 2019 — Jun 2019 [monthly]

    Completed NA

  8. Apr 2019 — May 2019 [monthly]

    Completed NA

  9. Mar 2019 — Apr 2019 [monthly]

    Completed NA

  10. Feb 2019 — Mar 2019 [monthly]

    Completed NA

  11. Jan 2019 — Feb 2019 [monthly]

    Completed NA

  12. Dec 2018 — Jan 2019 [monthly]

    Completed NA

  13. Nov 2018 — Dec 2018 [monthly]

    Completed NA

  14. Oct 2018 — Nov 2018 [monthly]

    Completed NA

  15. Sep 2018 — Oct 2018 [monthly]

    Completed NA

  16. Aug 2018 — Sep 2018 [monthly]

    Completed NA

  17. Jul 2018 — Aug 2018 [monthly]

    Completed NA

  18. Jun 2018 — Jul 2018 [monthly]

    Completed NA

  19. Jan 2017 — Jun 2018 [monthly]

    Completed NA

    First recorded

Mar 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Heart, Lung, and Blood Institute (NHLBI)
Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations